Toulouse Alzheimer’s Clinical Research Center Recovery after the COVID-19 Crisis: Telemedicine an Innovative Solution for Clinical Research during the Coronavirus Pandemic - 21/11/24
Doi : 10.14283/jpad.2020.32
C. Takeda 1, ⁎ 
, S. Guyonnet 2, 3, 4, 1, P.J. Ousset 1, M. Soto 2, 3, 1, B. Vellas 2, 3, 1
, S. Guyonnet 2, 3, 4, 1, P.J. Ousset 1, M. Soto 2, 3, 1, B. Vellas 2, 3, 1 1 Gérontopôle, Department of Geriatrics, CHU Toulouse, Toulouse, France
2 Inserm UMR 1027, Toulouse, France
3 University of Toulouse III, Toulouse, France
4 Cité de la Santé, Hôpital La Grave, Gérontopôle, CHU Toulouse, Place Lange, 31059, Toulouse cedex 9, France
a takeda.c@chu-toulouse.fr
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Il testo completo di questo articolo è disponibile in PDF.
Mappa
| Conflict of interest: The authors declare that they have no conflict of interest for the present paper. |
© 2020
THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 7 - N° 4
P. 301-304 - Settembre 2020 Ritorno al numero
Articolo precedente
- Authors response to D. Umbricht letter to the editor referring Futility Analyses in Alzheimer’s Disease (AD) Clinical Trials: A Risky Business. The Journal of Prevention of Alzheimer’s Disease, 2020
- P.S. Aisen, R. Raman
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.